Information

Related Research Units

Medicine Critical Care Research

Education

Medical School

Dartmouth Medical School
2002 Hanover NH

Graduate School

MPH Harvard School of Public Health
2014 Boston MA

Publications

  1. Development of an Interprofessional Clinician Training in Pediatric Serious Illness Communication. J Palliat Med. 2025 Feb 12. View Abstract
  2. Feasibility of a Serious Illness Communication Program for Pediatric Advance Care Planning. JAMA Netw Open. 2024 07 01; 7(7):e2424626. View Abstract
  3. "At Least I Can Push this Morphine": PICU Nurses' Approaches to Suffering Among Dying Children. J Pain Symptom Manage. 2024 Aug; 68(2):132-141.e2. View Abstract
  4. Reflecting Upon Our Stories: The Compendium of Narratives in Pediatric Critical Care Medicine. Pediatr Crit Care Med. 2024 Jul 01; 25(7):638-642. View Abstract
  5. Economic Hardship at the End of Life for Families of Children With Complex Chronic Conditions. J Pain Symptom Manage. 2024 Apr; 67(4):e313-e319. View Abstract
  6. The roles of preparation, location, and palliative care involvement in parent-perceived child suffering at the end of life. J Pediatr Nurs. 2023 Sep-Oct; 72:e166-e173. View Abstract
  7. Parent Preferences and Experiences in Advance Care Planning in the Neonatal Intensive Care Unit. Am J Perinatol. 2024 05; 41(S 01):e1783-e1791. View Abstract
  8. Advance Care Planning and Parent-Reported End-of-Life Outcomes in the Neonatal Intensive Care Unit. Am J Perinatol. 2024 05; 41(S 01):e1657-e1667. View Abstract
  9. The Case for Advance Care Planning in the NICU. Pediatrics. 2022 12 01; 150(6). View Abstract
  10. Relationships and Resources Supporting Children With Serious Illness and Their Parents. Hosp Pediatr. 2022 09 01; 12(9):832-842. View Abstract
  11. An Automatic Pediatric Palliative Care Consultation for Children Supported on Extracorporeal Membrane Oxygenation: A Survey of Perceived Benefits and Barriers. J Palliat Med. 2022 06; 25(6):952-957. View Abstract
  12. Bereaved Parent Perspectives on the Benefits and Burdens of Technology Assistance among Children with Complex Chronic Conditions. J Palliat Med. 2022 02; 25(2):250-258. View Abstract
  13. Is this as good as it gets? Implications of an asymptotic mortality decline and approaching the nadir in pediatric intensive care. Eur J Pediatr. 2022 Feb; 181(2):479-487. View Abstract
  14. Symptoms and Suffering at End of Life for Children With Complex Chronic Conditions. J Pain Symptom Manage. 2022 01; 63(1):88-97. View Abstract
  15. Clinical Care Strategies That Support Parents of Children With Complex Chronic Conditions. Pediatr Crit Care Med. 2021 07 01; 22(7):595-602. View Abstract
  16. The Words We Say. Pediatr Crit Care Med. 2021 05 01; 22(5):499-500. View Abstract
  17. Factors Affecting Recruitment and Participation of Bereaved Parents in Research: A Brief Report. J Pain Symptom Manage. 2021 09; 62(3):e213-e217. View Abstract
  18. Clinician Identified Barriers and Strategies for Advance Care Planning in Seriously Ill Pediatric Patients. J Pain Symptom Manage. 2021 09; 62(3):e100-e111. View Abstract
  19. Timing of Co-occurring Chronic Conditions in Children With Neurologic Impairment. Pediatrics. 2021 02; 147(2). View Abstract
  20. Weighing Distress and Benefit: Understanding the Research Participation Experiences of Bereaved Parents of Children With Complex Chronic Conditions. J Pain Symptom Manage. 2021 07; 62(1):39-47.e1. View Abstract
  21. Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19. Pediatrics. 2021 02; 147(2). View Abstract
  22. Development of a Stakeholder Driven Serious Illness Communication Program for Advance Care Planning in Children, Adolescents, and Young Adults with Serious Illness. J Pediatr. 2021 02; 229:247-258.e8. View Abstract
  23. A Breather during the Time of Breathlessness. J Palliat Med. 2021 02; 24(2):289. View Abstract
  24. "I Could Never Prepare for Something Like the Death of My Own Child": Parental Perspectives on Preparedness at End of Life for Children With Complex Chronic Conditions. J Pain Symptom Manage. 2020 12; 60(6):1154-1162.e1. View Abstract
  25. Chronic Medication Use in Children Insured by Medicaid: A Multistate Retrospective Cohort Study. Pediatrics. 2019 04; 143(4). View Abstract
  26. Association of Home Respiratory Equipment and Supply Use with Health Care Resource Utilization in Children. J Pediatr. 2019 04; 207:169-175.e2. View Abstract
  27. Advance Care Planning and Parent-Reported End-of-Life Outcomes in Children, Adolescents, and Young Adults With Complex Chronic Conditions. Crit Care Med. 2019 01; 47(1):101-108. View Abstract
  28. Patterns of Care at the End of Life for Children and Young Adults with Life-Threatening Complex Chronic Conditions. J Pediatr. 2018 02; 193:196-203.e2. View Abstract
  29. It's Very Treatable. J Palliat Med. 2018 Apr; 21(4):574-575. View Abstract
  30. Saying Goodbye. JAMA Pediatr. 2017 05 01; 171(5):417. View Abstract
  31. Medication Reconciliation Failures in Children and Young Adults With Chronic Disease During Intensive and Intermediate Care. Pediatr Crit Care Med. 2017 Apr; 18(4):370-377. View Abstract
  32. Suspected Cerebral Edema in Diabetic Ketoacidosis: Is There Still a Role for Head CT in Treatment Decisions? Pediatr Crit Care Med. 2017 Mar; 18(3):207-212. View Abstract
  33. 526: DO INTERMEDIATE CARE UNITS ALTER INTENSIVE CARE UTILIZATION FOR CHILDREN WITH MEDICAL COMPLEXITY? Crit Care Med. 2016 Dec; 44(12 Suppl 1):208. View Abstract
  34. 545: END-OF-LIFE CARE FOR CHILDREN WITH MEDICAL COMPLEXITY: DOES ADVANCE CARE PLANNING MATTER? Crit Care Med. 2016 Dec; 44(12 Suppl 1):213. View Abstract
  35. The authors reply. Pediatr Crit Care Med. 2014 Mar; 15(3):285-6. View Abstract
  36. Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality*. Pediatr Crit Care Med. 2013 Sep; 14(7):694-700. View Abstract
  37. Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J Neurosci. 2002 May 15; 22(10):4015-24. View Abstract
  38. Ratio of S-nitrosohomocyst(e)ine to homocyst(e)ine or other thiols determines neurotoxicity in rat cerebrocortical cultures. Neurosci Lett. 1999 Apr 16; 265(2):103-6. View Abstract
  39. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem. 1998 Sep; 71(3):946-59. View Abstract
  40. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci Lett. 1997 Nov 07; 236(3):139-42. View Abstract
  41. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 1997 May 27; 94(11):5923-8. View Abstract

Contact Danielle DeCourcey

Print Profile